Anastasia Domanova1, Juhani Virkanen2, Glenn Woods3, Stephane Mabic1
1Lab Water Solutions, Merck, Guyancourt, France, 2University of Helsinki, Helsinki, Finland, 3Agilent Technologies Ltd, Stockport, UK
This article demonstrates the suitability of fresh ultrapure water produced by a Milli-Q® water purification system for the analysis of elemental impurities according to US Pharmacopeia (USP) General Chapters <231>, <232>, and <233>.
It is crucial to monitor and control inorganic impurities in pharmaceuticals because some metals are used as reagents and catalysts during production and formulation processes. Moreover, metal impurities can be introduced into pharmaceutical products non-intentionally through contaminated reagents, or when products are in contact with pharmaceutical packaging or with metal surfaces during the development process. Hence, the United States Food and Drug Administration (FDA) and similar international health agencies have had long-standing regulations in place for controlling harmful impurities in pharmaceutical products marketed for human consumption. Historically, four heavy metals (arsenic, cadmium, lead and mercury), or the “Big Four”, were required to be tested according to the United States Pharmacopeial Convention (USP) General Chapter <231> “Heavy Metal Limit Test”. However, new mandatory guidelines to control potential toxic impurities in drugs were recently established in two USP General Chapters <232>1 and <233>.2
These recent chapters in the USP subdivide the metals desired for analyses into several groups. In this article, the first and the second groups comprising 15 metals (cadmium, lead, arsenic, mercury, iridium, osmium, palladium, platinum, rhodium, ruthenium, chromium, molybdenum, nickel, vanadium and copper) are addressed. Other elemental impurities listed in the FDA’s Guidance for Industry to Q3D Elemental Impurities3 and in the European Medicine Agency’s (EMA) Guideline on the Specification Limits for Residues of Metal Catalysts or Metal Reagents4 are addressed in an extended ICP-MS article for pharma.
Inductively coupled plasma–mass spectrometry (ICP-MS) is a sensitive technique for analyses of elemental impurities.2 Ultrapure water is a main reagent in ICP-MS and is used extensively from sample preparation to analytical instrument cleaning (Figure 1). Milli-Q® ultrapure water purification systems are designed to deliver water that meets or exceeds the water quality standards described in various pharmacopeias. However, water selected as a reagent must not only comply with specific pharmacopeial standards, but must also meet the requirements of modern instrumentation to ensure the best performance of ICP-MS instrumentation.5 Thus, reagent water of very high quality must be selected to avoid sample and analytical instrument contamination and must be free of the elements being measured.6 The aim of this study was to evaluate the suitability of fresh ultrapure water produced using Milli-Q® ultrapure water purification systems for use in ICP-MS trace element analyses.
Figure 1.Different types of uses for ultrapure water in ICP-MS analysis.
In the pharmaceutical industry, element analyses are performed in the range of mg/L (ppm) to sub-μg/L (sub-ppb) levels. As sensitivity, accuracy, precision and recovery must be appropriately demonstrated during the method validation process, achieving a low and stable background equivalent concentration (BEC) as well as low and consistent detection limits is critical. Table 1 presents the BEC and limit of detection (LOD) in Milli-Q® ultrapure water for each element in ng/L (ppt) level.
From Table 1, it can be observed that certain elements are present in slightly higher levels than sub-ppt. This can be explained by contamination coming from the laboratory environment, since the present analyses were performed under normal laboratory conditions.7 In case there is a need to achieve significantly lower levels of elements, it is reasonable to apply an additional polishing step, such as a Milli-Q® IQ Element purification unit which makes it possible to obtain BECs at sub-ppt and ppq levels in a clean room or metal-free laboratory environment.8
Tap water was purified in two steps to obtain ultrapure water:
The ultrapure water samples were analyzed as follows for levels of:
All experiments were performed under regular laboratory conditions (not in a clean room).
Agilent® 7700s instrumental details and parameters: PFA-50 nebulizer, PFA spray chamber, sapphire inert torch, quartz 2.5 mm i.d. torch injector, platinum sample and skimmer cone, RF power 600/1600 W, sampling position 12 / 8 mm, carrier gas flow 0.90 L/min, makeup gas flow 0.32 / 0.51 L/min, auto detector mode, calibration through 1, 5, 10, 50 ng/L.
Agilent® 7500s instrumental details and parameters: quartz nebulizer, quartz spray chamber, quartz i.d. torch injector, nickel sample and skimmer cone, RF power 1300/1550 W, sampling position 8 mm, carrier gas flow 0.96 L/min, makeup gas flow 0.23 L/min, auto detector mode, calibration through 1, 20, 50, 100 ng/L.
Containers were all PFA pre-cleaned with ultrapure water. All ultrapure water samples (resistivity of 18.2 MΩ·cm and TOC below 5 ppb) from Milli-Q® water purification systems were analyzed immediately after water collection.
Low levels of elemental impurities in ultrapure water produced by Milli-Q® ultrapure water purification systems were demonstrated. Laboratories in the pharmaceutical industry performing trace element analyses can rely on Milli-Q® water purification systems to produce high-purity water that meets their stringent requirements. Choosing water from Milli-Q® ultrapure water systems for element analyses will help to ensure the generation of accurate and reliable data.
To continue reading please sign in or create an account.Don't Have An Account?